GSK to shut down Indian plant; Hospira yanks one painkiller lot on overdose risk;

 @FiercePharma: China's animal health market is growing doggone fast. Bayer, Sanofi, etc. aim to take advantage--Bloomberg. Report | Follow @FiercePharma

> GlaxoSmithKline ($GSK) is preparing to shutter a factory in western India after all its workers there accepted early retirement. Report

> Hospira ($HSP) pulled one lot of its hydromorphone painkiller after reports that its injection device might be overfilled, increasing the risk of overdose. Report

> Roche ($RHHBY) won the first European approval for its targeted breast cancer drug Perjeta as Swiss regulators cleared the treatment for sale. Report

> Korean drugmakers are looking to expand geographically as government price cuts roll into effect. Report

> Stanford University demanded that the dermatology specialist Nu Skin stop using one of its researcher's names in its promotional materials. Report

Medical Device News

 @FierceMedDev: Teleflex has closed the $45.2M sale of its ortho unit to Tecomet. News | Follow @FierceMedDev

 @MarkHFierce: We have a great roster of new stories this week in FierceBiotechResearch. Check them out! More | Follow @MarkHFierce

 @DamianFierce: Teleflex has closed the $45.2M sale of its ortho unit to Tecomet. News | Follow @DamianFierce

> Indiana officials say device tax will hamstring state industry. Report

> Crowded market could blunt profits for hypertension techs. More

> FDA demands 3-year study of St. Jude's leads. Article

Biotech News

 @FierceBiotech: Geron generates spark from cancer pipeline. News | Related report by @MarkHFierce: Report | Follow @FierceBiotech

 @JohnCFierce: CRO market headed to $1B in India according to Frost & Sullivan. Report | Follow @JohnCFierce

 @RyanMFierce: Yes, the Farber doc did say "mouse's mojo." But the study of rodents', ah, zest could pave way to "the pill" for guys. More | Follow @RyanMFierce

> Gene patent ruling seen as win for Myriad, biotech industry. Story

> Harvard docs happen upon potential male birth control with cancer compound. Article

> Quintiles cozies up to Eli Lilly with new Indy office. Story

> GSK runs to PhIII with upbeat data on drug for severe asthma. More

And Finally... A U.S. appeals court reaffirmed its ruling that human genes can be patented. Report